{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:06:21Z","timestamp":1793221581783,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s40123-023-00797-8","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T09:02:42Z","timestamp":1694509362000},"page":"2863-2880","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Factors Affecting Glaucoma Medication Adherence and Interventions to Improve Adherence: A Narrative Review"],"prefix":"10.1007","volume":"12","author":[{"given":"Shannan G.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0717-0638","authenticated-orcid":false,"given":"Bobeck S.","family":"Modjtahedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,12]]},"reference":[{"key":"797_CR1","unstructured":"Centers for Disease Control and Prevention. Don\u2019t let glaucoma steal your sight! Centers for Disease Control and Prevention. 2020."},{"issue":"11","key":"797_CR2","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"Y-C Tham","year":"2014","unstructured":"Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology. 2014;121(11):2081\u201390.","journal-title":"Ophthalmology"},{"issue":"4","key":"797_CR3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/09286586.2016.1193207","volume":"23","author":"A Pleet","year":"2016","unstructured":"Pleet A, Sulewski M, Salowe RJ, Fertig R, Salinas J, Rhodes A, et\u00a0al. Risk factors associated with progression to blindness from primary open-angle glaucoma in an African-American population. Ophthalmic Epidemiol. 2016;23(4):248\u201356.","journal-title":"Ophthalmic Epidemiol"},{"issue":"9","key":"797_CR4","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1001\/jamaophthalmol.2015.1671","volume":"133","author":"DM Blumberg","year":"2015","unstructured":"Blumberg DM, Prager AJ, Liebmann JM, Cioffi GA, De Moraes CG. Cost-related medication nonadherence and cost-saving behaviors among patients with glaucoma before and after the implementation of medicare part D. JAMA Ophthalmol. 2015;133(9):985\u20136.","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"797_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ophtha.2009.06.024","volume":"116","author":"JC Tsai","year":"2009","unstructured":"Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009;116(11):30\u20136.","journal-title":"Ophthalmology"},{"issue":"10","key":"797_CR6","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl A, Leske MC, Bengtsson B. Reduction of intraocular pressure and glaucoma progression. Arch Ophthalmol. 2002;120(10):1268\u201379.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"797_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, et\u00a0al. The ocular hypertension treatment study. Arch Ophthalmol. 2002;120(6):701\u201313.","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"797_CR8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1097\/OPX.0000000000000009","volume":"90","author":"LE Dreer","year":"2013","unstructured":"Dreer LE, Girkin CA, Campbell L, Wood A, Gao L, Owsley C. Glaucoma medication adherence among African Americans: program development. Optom Vis Sci. 2013;90(8):883\u201397.","journal-title":"Optom Vis Sci"},{"issue":"9","key":"797_CR9","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.ophtha.2005.02.030","volume":"112","author":"DS Friedman","year":"2005","unstructured":"Friedman DS, Nordstrom B, Mozaffari E, Quigley HA. Glaucoma management among individuals enrolled in a single comprehensive insurance plan. Ophthalmology. 2005;112(9):1500\u20134.","journal-title":"Ophthalmology"},{"issue":"4","key":"797_CR10","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1001\/archopht.122.4.532","volume":"122","author":"DS Friedman","year":"2004","unstructured":"Friedman DS, Wolfs RCW, O\u2019Colmain BJ, et\u00a0al. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122(4):532\u20138.","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"797_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0161-6420(99)90147-1","volume":"106","author":"DC Musch","year":"1999","unstructured":"Musch DC, Lichter PR, Guire KE, Standardi CL. The collaborative initial glaucoma treatment study study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999;106(4):653\u201362.","journal-title":"Ophthalmology"},{"issue":"4","key":"797_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/jop.2018.0134","volume":"35","author":"C Wolfram","year":"2019","unstructured":"Wolfram C, Stahlberg E, Pfeiffer N. Patient-reported nonadherence with glaucoma therapy. J Ocul Pharmacol Ther. 2019;35(4):223\u20138.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"11","key":"797_CR13","first-page":"654","volume":"67","author":"SF Laster","year":"1996","unstructured":"Laster SF, Fleming JB, Martin JL. The effect of a medication alarm device on patient compliance with topical pilocarpine. J Am Optom Assoc. 1996;67(11):654\u20138.","journal-title":"J Am Optom Assoc"},{"issue":"1","key":"797_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1475-1313.2003.00155.x","volume":"24","author":"S Deokule","year":"2004","unstructured":"Deokule S, Sadiq S, Shah S. Chronic open angle glaucoma: patient awareness of the nature of the disease, topical medication, compliance and the prevalence of systemic symptoms. Ophthalmic Physiol Opt. 2004;24(1):9\u201315.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"6","key":"797_CR15","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.ophtha.2004.12.035","volume":"112","author":"CM Olthoff","year":"2005","unstructured":"Olthoff CM, Schouten JS, van de Borne BW, Webers CA. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension: an evidence-based review. Ophthalmology. 2005;112(6):953\u201361.","journal-title":"Ophthalmology"},{"key":"797_CR16","first-page":"1","volume":"111","author":"SL Mansberger","year":"2013","unstructured":"Mansberger SL, Sheppler CR, McClure TM, et\u00a0al. Psychometrics of a new questionnaire to assess glaucoma adherence: the glaucoma treatment compliance assessment tool. Trans Am Ophthalmol Soc. 2013;111:1\u201316.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"797_CR17","first-page":"1","volume":"4","author":"H Waterman","year":"2013","unstructured":"Waterman H, Evans JR, Gray TA, Henson D, Harper R. Interventions for improving adherence to ocular hypotensive therapy. Cochrane Database Syst Rev. 2013;4:1\u201373.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"797_CR18","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1001\/archopht.1991.01080080050026","volume":"109","author":"A Sommer","year":"1991","unstructured":"Sommer A, Tielsch JM, Katz J, et\u00a0al. Relationship between intraocular pressure and primary open angle glaucoma among white and Black Americans: the baltimore eye study. Arch Ophthalmol. 1991;109(8):1090\u20135.","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"797_CR19","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.ophtha.2004.01.025","volume":"111","author":"R Varma","year":"2004","unstructured":"Varma R, Ying-Lai M, Francis BA, et\u00a0al. Prevalence of open-angle glaucoma and ocular hypertension in Latinos. Ophthalmology. 2004;111(8):1439\u201348.","journal-title":"Ophthalmology"},{"issue":"5","key":"797_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/IJG.0b013e3182741f1c","volume":"23","author":"G Rees","year":"2014","unstructured":"Rees G, Chong X-L, Cheung CY, et\u00a0al. Beliefs and adherence to glaucoma treatment: a comparison of patients from diverse cultures. J Glaucoma. 2014;23(5):293\u20138.","journal-title":"J Glaucoma"},{"issue":"7","key":"797_CR21","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/archophthalmol.2011.163","volume":"129","author":"Y Murakami","year":"2011","unstructured":"Murakami Y, Lee BW, Duncan M, et\u00a0al. Racial and ethnic disparities in adherence to glaucoma follow-up visits in a county hospital population. Arch Ophthalmol. 2011;129(7):872\u20138.","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"797_CR22","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/IJG.0b013e31821dac86","volume":"21","author":"LE Dreer","year":"2012","unstructured":"Dreer LE, Girkin C, Mansberger SL. Determinants of medication adherence to topical glaucoma therapy. J Glaucoma. 2012;21(4):234\u201340.","journal-title":"J Glaucoma"},{"issue":"1","key":"797_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/02713683.2014.1002045","volume":"41","author":"LE Dreer","year":"2016","unstructured":"Dreer LE, Owsley C, Campbell L, Gao L, Wood A, Girkin CA. Feasibility, patient acceptability, and preliminary efficacy of a culturally informed, health promotion program to improve glaucoma medication adherence among African Americans: \u201cglaucoma management optimism for African Americans living with glaucoma\u201d (goal). Curr Eye Res. 2016;41(1):50\u20138.","journal-title":"Curr Eye Res"},{"issue":"9","key":"797_CR24","first-page":"1532","volume":"98","author":"R Benkert","year":"2006","unstructured":"Benkert R, Peters RM, Clark R, Keves-Foster K. Effects of perceived racism, cultural mistrust and trust in providers on satisfaction with care. J Natl Med Assoc. 2006;98(9):1532\u201340.","journal-title":"J Natl Med Assoc"},{"issue":"1","key":"797_CR25","first-page":"5","volume":"38","author":"B Chae","year":"2013","unstructured":"Chae B, Cakiner-Egilmez T, Desai M. Glaucoma medications. Insight. 2013;38(1):5\u201310.","journal-title":"Insight"},{"key":"797_CR26","doi-asserted-by":"crossref","unstructured":"Ederer F, Gaasterland DE, Sullivan EK, AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): study design and methods and baseline characteristics of study patients.\u00a0Control Clin Trials. 1994; 15(4) : 299\u2013325.","DOI":"10.1016\/0197-2456(94)90046-9"},{"issue":"1","key":"797_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ajo.2007.08.041","volume":"145","author":"NR Rylander","year":"2008","unstructured":"Rylander NR, Vold SD. Cost analysis of glaucoma medications. Am J Ophthalmol. 2008;145(1):106\u201313.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"797_CR28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1001\/jamaophthalmol.2022.0053","volume":"140","author":"AG Ross","year":"2022","unstructured":"Ross AG, Higginbotham EJ. Unpacking the barriers to medication adherence may move US closer to Eye Health Equity. JAMA Ophthalmol. 2022;140(4):361\u20132.","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"797_CR29","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.ophtha.2007.11.023","volume":"115","author":"DS Friedman","year":"2008","unstructured":"Friedman DS, Hahn SR, Gelb L, et\u00a0al. Doctor\u2013patient communication, health-related beliefs, and adherence in glaucoma. Ophthalmology. 2008;115(8):1320\u20137.","journal-title":"Ophthalmology"},{"issue":"7","key":"797_CR30","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1097\/IJG.0000000000000320","volume":"25","author":"PA Newman-Casey","year":"2016","unstructured":"Newman-Casey PA, Shtein RM, Coleman AL, Herndon L, Lee PP. Why patients with glaucoma lose vision: the patient perspective. J Glaucoma. 2016;25(7):668\u201375.","journal-title":"J Glaucoma"},{"issue":"3","key":"797_CR31","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ophtha.2005.10.034","volume":"113","author":"B Sleath","year":"2006","unstructured":"Sleath B, Robin AL, Covert D, Byrd JE, Tudor G, Svarstad B. Patient-reported behavior and problems in using glaucoma medications. Ophthalmology. 2006;113(3):431\u20136.","journal-title":"Ophthalmology"},{"issue":"4","key":"797_CR32","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ajo.2005.04.051","volume":"140","author":"BL Nordstrom","year":"2005","unstructured":"Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol. 2005;140(4):598\u2013609.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"797_CR33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5005\/jp-journals-10008-1182","volume":"9","author":"VS Gupta","year":"2015","unstructured":"Gupta VS, Sethi H, Naik M. Strategies to improve glaucoma compliance based on cross-sectional response-based data in a tertiary healthcare center: the glauco-jung study. J Curr Glaucoma Pract. 2015;9(2):38\u201346.","journal-title":"J Curr Glaucoma Pract"},{"issue":"6","key":"797_CR34","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s40258-019-00497-0","volume":"17","author":"M Bilger","year":"2019","unstructured":"Bilger M, Wong TT, Lee JY, et\u00a0al. Using adherence-contingent rebates on chronic disease treatment costs to promote medication adherence: results from a randomized controlled trial. Appl Health Econ Health Policy. 2019;17(6):841\u201355.","journal-title":"Appl Health Econ Health Policy"},{"issue":"4","key":"797_CR35","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1001\/jamaophthalmol.2022.0055","volume":"140","author":"A Delavar","year":"2022","unstructured":"Delavar A, Radha Saseendrakumar B, Weinreb RN, Baxter SL. Racial and ethnic disparities in cost-related barriers to medication adherence among patients with glaucoma enrolled in the National Institutes of Health all of us research program. JAMA Ophthalmol. 2022;140(4):354\u201361.","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"797_CR36","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.ophtha.2020.04.037","volume":"127","author":"EM Chen","year":"2020","unstructured":"Chen EM, Kombo N, Teng CC, Mruthyunjaya P, Nwanyanwu K, Parikh R. Ophthalmic medication expenditures and out-of-pocket spending. Ophthalmology. 2020;127(10):1292\u2013302.","journal-title":"Ophthalmology"},{"issue":"5","key":"797_CR37","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1001\/archopht.126.5.718","volume":"126","author":"MS Juzych","year":"2008","unstructured":"Juzych MS, Randhawa S, Shukairy A. Functional health literacy in patients with glaucoma in urban settings. Arch Ophthalmol. 2008;126(5):718\u201324.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"797_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ajo.2006.03.018","volume":"142","author":"KW Muir","year":"2006","unstructured":"Muir KW, Santiago-Turla C, Stinnett SS, et\u00a0al. Health literacy and adherence to glaucoma therapy. Am J Ophthalmol. 2006;142(2):223\u20136.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"797_CR39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/IJG.0b013e31820bd2e1","volume":"21","author":"R Gupta","year":"2012","unstructured":"Gupta R, Patil B, Shah BM, Bali SJ, Mishra SK, Dada T. Evaluating eye drop instillation technique in glaucoma patients. J Glaucoma. 2012;21(3):189\u201392.","journal-title":"J Glaucoma"},{"issue":"1","key":"797_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ogla.2021.05.004","volume":"5","author":"JM Kang","year":"2022","unstructured":"Kang JM, Chatterjee A, Rosdahl JA, et\u00a0al. Health literacy and success with glaucoma drop administration. Ophthalmol Glaucoma. 2022;5(1):26\u201331.","journal-title":"Ophthalmol Glaucoma"},{"issue":"11","key":"797_CR41","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/S0161-6420(98)91134-4","volume":"105","author":"O Kosoko","year":"1998","unstructured":"Kosoko O, Quigley HA, Vitale S, Enger C, Kerrigan L, Tielsch JM. Risk factors for noncompliance with glaucoma follow-up visits in a residents\u2019 eye clinic. Ophthalmology. 1998;105(11):2105\u201311.","journal-title":"Ophthalmology"},{"issue":"2","key":"797_CR42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.pec.2011.09.009","volume":"87","author":"KW Muir","year":"2012","unstructured":"Muir KW, Ventura A, Stinnett SS, Enfiedjian A, Allingham RR, Lee PP. The influence of health literacy level on an educational intervention to improve glaucoma medication adherence. Patient Educ Couns. 2012;87(2):160\u20134.","journal-title":"Patient Educ Couns"},{"issue":"1","key":"797_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ogla.2021.06.001","volume":"5","author":"DJ Miller","year":"2022","unstructured":"Miller DJ, Niziol LM, Elam AR, et\u00a0al. Demographic, clinical, and psychosocial predictors of change in medication adherence in the support, educate, empower program. Ophthalmol Glaucoma. 2022;5(1):47\u201357.","journal-title":"Ophthalmol Glaucoma"},{"issue":"57","key":"797_CR44","first-page":"1","volume":"12","author":"H Cate","year":"2012","unstructured":"Cate H, Bhattacharya D, Clark A, Fordham R, Notley C, Broadway DC. Protocol for a randomised controlled trial to estimate the effects and costs of a patient centred educational intervention in glaucoma management. BMC Ophthalmol. 2012;12(57):1\u201313.","journal-title":"BMC Ophthalmol"},{"issue":"32","key":"797_CR45","first-page":"1","volume":"14","author":"H Cate","year":"2014","unstructured":"Cate H, Bhattacharya D, Clark A, Fordham R, Holland R, Broadway DC. Improving adherence to glaucoma medication: a randomised controlled trial of a patient-centred intervention (the norwich adherence glaucoma study). BMC Ophthalmol. 2014;14(32):1\u201310.","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"797_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1586\/17469899.2016.1134318","volume":"11","author":"PA Newman-Casey","year":"2016","unstructured":"Newman-Casey PA, Dayno M, Robin AL. Systematic review of educational interventions to improve glaucoma medication adherence: an update in 2015. Expert Rev Ophthalmol. 2016;11(1):5\u201320.","journal-title":"Expert Rev Ophthalmol"},{"issue":"3","key":"797_CR47","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/eye.2011.269","volume":"26","author":"TA Gray","year":"2011","unstructured":"Gray TA, Fenerty C, Harper R, et\u00a0al. Individualized patient care as an adjunct to standard care for promoting adherence to ocular hypotensive therapy: an exploratory randomized controlled trial. Eye. 2011;26(3):407\u201317.","journal-title":"Eye"},{"issue":"6197","key":"797_CR48","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1136\/bmj.2.6197.1031","volume":"2","author":"SE Norell","year":"1979","unstructured":"Norell SE. Improving medication compliance: a randomised clinical trial. BMJ. 1979;2(6197):1031\u20133.","journal-title":"BMJ"},{"issue":"2","key":"797_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ophtha.2008.09.004","volume":"116","author":"CO Okeke","year":"2009","unstructured":"Okeke CO, Quigley HA, Jampel HD, et\u00a0al. Adherence with topical glaucoma medication monitored electronically the Travatan dosing aid study. Ophthalmology. 2009;116(2):191\u20139.","journal-title":"Ophthalmology"},{"issue":"7","key":"797_CR50","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.ophtha.2009.11.026","volume":"117","author":"SR Hahn","year":"2010","unstructured":"Hahn SR, Friedman DS, Quigley HA, et\u00a0al. Effect of patient-centered communication training on discussion and detection of nonadherence in glaucoma. Ophthalmology. 2010;117(7):1339\u201347.","journal-title":"Ophthalmology"},{"key":"797_CR51","unstructured":"Boyd, K. Glaucoma eye drops. Am Acad Ophthalmol. 2023."},{"issue":"5","key":"797_CR52","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2105\/AJPH.83.5.711","volume":"83","author":"JH Gurwitz","year":"1993","unstructured":"Gurwitz JH, Glynn RJ, Monane M, et\u00a0al. Treatment for glaucoma: adherence by the elderly. Am J Public Health. 1993;83(5):711\u20136.","journal-title":"Am J Public Health"},{"issue":"5","key":"797_CR53","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ophtha.2004.12.026","volume":"112","author":"A Robin","year":"2005","unstructured":"Robin A, Covert D. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy? Ophthalmology. 2005;112(5):863\u20138.","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-023-00797-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-023-00797-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-023-00797-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T02:18:36Z","timestamp":1699669116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-023-00797-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["797"],"URL":"https:\/\/doi.org\/10.1007\/s40123-023-00797-8","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,12]]},"assertion":[{"value":"9 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Shannan\u00a0G. Moore and Grace Richter declare that they have no competing interests. Bobeck S. Modjtahedi receives research support from Genentech and VoxelCloud.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new data with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}